NCT00519636

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 360 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.

Detailed description

A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy, Patient Preference and Experience of One-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects with Seasonal Allergic Rhinitis (FFU105927)

Conditions

• Rhinitis, Allergic, Perennial

Interventions

Type	Name	Description
DRUG	FPNS	fluticasone propionate nasal spray
DRUG	FFNS	fluticasone furoate nasal spray
DRUG	placebo FFNS	placebo nasal spray matching fluticasone furoate nasal spray
DRUG	placebo FPNS	placebo nasal spray matching fluticasone propionate nasal spray

Timeline

• Start date: 2007-08-01
• Primary completion: 2007-11-01
• Completion: 2007-11-01
• First posted: 2007-08-22
• Last updated: 2016-12-09
• Results posted: 2010-01-15

Locations

28 sites across 1 country: United States